News from the FDA/CDC
News from the FDA/CDC
FDA moves to expand coronavirus testing capacity; CDC clarifies testing criteria
Close to a million tests will be available by week’s end, predicted HHS Secretary Alex Azar
FDA/CDC
Upcoming vaccine may offset surge in polio subtypes
Response to polio outbreaks involves fast-tracking a modified oral vaccine.
News from the FDA/CDC
FDA issues public health warning recommending against cesium salt usage
Cesium salts are sometimes advertised as an alternative treatment for cancer.
News from the FDA/CDC
CDC: Opioid prescribing and use rates down since 2010
News from the FDA/CDC
Zika virus: Birth defects rose fourfold in U.S. hardest-hit areas
U.S. jurisdictions without local transmission of the virus saw no increase in infants born with brain abnormalities and/or microcephaly or with...
News from the FDA/CDC
Washington state patient is first U.S. case of novel coronavirus
Feature
FDA advisers set high bar for new opioids
Two days of FDA discussion over three new opioids seeking U.S. approval highlighted the barriers these drugs now face.
News from the FDA/CDC
FDA committee rejects oxycodegol, new opioid designed for less abuse
A novel opioid molecule designed to have less abuse potential with slower CNS entry received a unanimous FDA committee turn down.
Latest News
FDA approves diazepam nasal spray for seizure clusters
Valtoco may be administered by a care partner outside of a medical setting for the treatment of frequent seizure activity that is distinct from a...
FDA/CDC
FDA okays first generics for Eliquis
“These approvals mark the first generic approvals of a direct oral anticoagulant.”
FDA/CDC
FDA okays ubrogepant for acute migraine treatment
ACHIEVE I and ACHIEVE II demonstrate efficacy.